Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. CL
3. SNDK
4. TAP
5. DELL
6. ROIV
7. ANET
8. NKE
9. PANW
10. SPG

Go back to Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer
(NASDAQ: TNGX) Delayed: 22.52 -0.24 (1.05%)
Previous Close $22.76    52 Week High $ 
Open $22.48    52 Week Low $ 
Day High $22.94    P/E N/A 
Day Low $22.29    EPS $ 
Volume 1,457,381